T1	PROC 46 66	Detección del cáncer
#1	AnnotatorNotes T1	C0199230; Screening for cancer; Diagnostic Procedure
T2	DISO 60 66	cáncer
#2	AnnotatorNotes T2	C0006826; Malignant Neoplasms; Neoplastic Process
T3	PROC 75 92	técnica de imagen
#3	AnnotatorNotes T3	C0079595; Imaging Techniques; Diagnostic Procedure
T4	PROC 109 125	detectar tumores
T5	DISO 118 125	tumores
#4	AnnotatorNotes T5	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C0577559; Mass of body structure; Finding
T6	DISO 155 187	enfermedad tromboenbolica venosa
T7	ANAT 181 187	venosa
#5	AnnotatorNotes T7	C0042449; Veins; Body Part, Organ, or Organ Component | C1278960; Entire vein; Body Part, Organ, or Organ Component
T8	DISO 235 241	cáncer
#6	AnnotatorNotes T8	C0006826; Malignant Neoplasms; Neoplastic Process
T9	PROC 302 322	Detección del cáncer
#7	AnnotatorNotes T9	C0199230; Screening for cancer; Diagnostic Procedure
T10	DISO 316 322	cáncer
#8	AnnotatorNotes T10	C0006826; Malignant Neoplasms; Neoplastic Process
T11	PROC 327 330	PET
#9	AnnotatorNotes T11	C0032743; Positron-Emission Tomography; Diagnostic Procedure
T12	PROC 331 334	TAC
#10	AnnotatorNotes T12	C0040405; X-Ray Computed Tomography; Diagnostic Procedure
T13	DISO 352 384	enfermedad tromboembólica venosa
T14	ANAT 378 384	venosa
#11	AnnotatorNotes T14	C0042449; Veins; Body Part, Organ, or Organ Component | C1278960; Entire vein; Body Part, Organ, or Organ Component
T15	DISO 432 438	cáncer
#12	AnnotatorNotes T15	C0006826; Malignant Neoplasms; Neoplastic Process
T16	PROC 544 547	PET
#13	AnnotatorNotes T16	C0032743; Positron-Emission Tomography; Diagnostic Procedure
T17	PROC 548 551	TAC
#14	AnnotatorNotes T17	C0040405; X-Ray Computed Tomography; Diagnostic Procedure
T18	PROC 557 572	detectar cáncer
T19	DISO 566 572	cáncer
#15	AnnotatorNotes T19	C0006826; Malignant Neoplasms; Neoplastic Process
T20	DISO 597 629	enfermedad tromboembólica venosa
T21	ANAT 623 629	venosa
#16	AnnotatorNotes T21	C0042449; Veins; Body Part, Organ, or Organ Component | C1278960; Entire vein; Body Part, Organ, or Organ Component
T22	PROC 513 532	conocer la eficacia
#17	AnnotatorNotes T22	C1707887; Efficacy Study; Research Activity
T23	DISO 718 750	Enfermedad tromboembólica venosa
T24	ANAT 744 750	venosa
#18	AnnotatorNotes T24	C0042449; Veins; Body Part, Organ, or Organ Component | C1278960; Entire vein; Body Part, Organ, or Organ Component
T25	PROC 803 814	Diagnóstico
#19	AnnotatorNotes T25	C0011900; Diagnosis; Diagnostic Procedure
T26	DISO 818 850	enfermedad tromboembólica venosa
T27	ANAT 844 850	venosa
#20	AnnotatorNotes T27	C0042449; Veins; Body Part, Organ, or Organ Component | C1278960; Entire vein; Body Part, Organ, or Organ Component
T28	DISO 852 909	trombosis venosa profunda proximal de miembros inferiores
T29	ANAT 890 909	miembros inferiores
#21	AnnotatorNotes T29	C0023216; Lower Extremity; Body Part, Organ, or Organ Component | C1269079; Entire lower limb; Body Part, Organ, or Organ Component
T30	DISO 911 928	embolia de pulmón
T31	PROC 1165 1176	seguimiento
#22	AnnotatorNotes T31	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T32	DISO 1190 1207	Hipersensibilidad
#23	AnnotatorNotes T32	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding
T33	PROC 1255 1258	PET
#24	AnnotatorNotes T33	C0032743; Positron-Emission Tomography; Diagnostic Procedure
T34	PROC 1259 1262	TAC
#25	AnnotatorNotes T34	C0040405; X-Ray Computed Tomography; Diagnostic Procedure
T35	CHEM 1264 1286	8-fluor desoxi-glucosa
#26	AnnotatorNotes T35	C0046056; fluorodeoxyglucose F18; Indicator, Reagent, or Diagnostic Aid · Organic Chemical
T36	CHEM 1318 1329	excipientes
#27	AnnotatorNotes T36	C0015237; Pharmaceutical Excipient; Biomedical or Dental Material
T37	PROC 243 278	Ensayo clínico aleatorizado abierto
T38	PROC 440 475	Ensayo clínico aleatorizado abierto
T39	PROC 638 660	pruebas de diagnostico
#28	AnnotatorNotes T39	C0871311; Screening test; Health Care Activity
T40	ANAT 862 868	venosa
#29	AnnotatorNotes T40	C0042449; Veins; Body Part, Organ, or Organ Component | C1278960; Entire vein; Body Part, Organ, or Organ Component
T41	ANAT 922 928	pulmón
#30	AnnotatorNotes T41	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T42	PROC 1080 1104	consentimiento informado
#31	AnnotatorNotes T42	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T43	CHEM 1211 1220	contraste
#32	AnnotatorNotes T43	C0009924; Contrast Media; Indicator, Reagent, or Diagnostic Aid
T44	CHEM 1288 1293	18FDG
#33	AnnotatorNotes T44	C0046056; fluorodeoxyglucose F18; Indicator, Reagent, or Diagnostic Aid · Organic Chemical
T45	Date 13 17	2018
T46	LIVB 141 150	pacientes
#34	AnnotatorNotes T46	C0030705; Patients; Patient or Disabled Group
T48	Spec_cue 213 222	riesgo de
T49	LIVB 338 347	pacientes
#35	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T51	Spec_cue 410 419	riesgo de
T52	LIVB 583 592	pacientes
#36	AnnotatorNotes T52	C0030705; Patients; Patient or Disabled Group
T53	Age 780 798	Mayores de 18 años
T56	Date 1061 1065	2016
T57	Neg_cue 1135 1151	Imposibilidad de
A1	Assertion T8 Speculated
A2	Assertion T15 Speculated
A3	Assertion T31 Negated
A4	Status T32 History_of
#37	AnnotatorNotes T37	C1709323; Open Label Study; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
#38	AnnotatorNotes T6	C1997614; Thromboembolism of vein; Pathologic Function 
#39	AnnotatorNotes T13	C1997614; Thromboembolism of vein; Pathologic Function 
#40	AnnotatorNotes T20	C1997614; Thromboembolism of vein; Pathologic Function 
#41	AnnotatorNotes T23	C1997614; Thromboembolism of vein; Pathologic Function 
#42	AnnotatorNotes T26	C1997614; Thromboembolism of vein; Pathologic Function 
#43	AnnotatorNotes T38	C1709323; Open Label Study; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
#44	AnnotatorNotes T18	C0199230; Screening for cancer; Diagnostic Procedure
#45	AnnotatorNotes T30	C0034065; Pulmonary Embolism; Pathologic Function 
T47	Quantifier_or_Qualifier 191 200	provocada
A5	Assertion T47 Negated
#46	AnnotatorNotes T47	C1444748; Triggered by; Qualitative Concept (?)
T50	Neg_cue 188 190	no
T54	Quantifier_or_Qualifier 388 397	provocada
A6	Assertion T54 Negated
#47	AnnotatorNotes T54	C1444748; Triggered by; Qualitative Concept (?)
T55	Neg_cue 385 387	no
T58	Neg_cue 938 940	no
T59	Quantifier_or_Qualifier 941 950	provocado
A7	Assertion T59 Negated
#48	AnnotatorNotes T59	C1444748; Triggered by; Qualitative Concept (?)
T60	Quantifier_or_Qualifier 126 137	precozmente
#49	AnnotatorNotes T60	C1279919; Early; Temporal Concept
R4	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T60	
R5	Experiences Arg1:T46 Arg2:T1	
R6	Experiences Arg1:T46 Arg2:T2	
R7	Experiences Arg1:T46 Arg2:T3	
R8	Experiences Arg1:T46 Arg2:T4	
R9	Experiences Arg1:T46 Arg2:T5	
R10	Experiences Arg1:T46 Arg2:T6	
R11	Location_of Arg1:T7 Arg2:T6	
R12	Negation Arg1:T50 Arg2:T47	
R13	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T47	
R14	Speculation Arg1:T48 Arg2:T8	
T61	Observation 208 222	algo riesgo de
#50	AnnotatorNotes T61	C0332167; High risk of; Finding
R15	Before Arg1:T61 Arg2:T8	
R16	Experiences Arg1:T46 Arg2:T61	
R20	Experiences Arg1:T49 Arg2:T9	
R21	Experiences Arg1:T49 Arg2:T11	
R22	Experiences Arg1:T49 Arg2:T12	
R23	Experiences Arg1:T49 Arg2:T13	
R24	Location_of Arg1:T14 Arg2:T13	
R25	Negation Arg1:T55 Arg2:T54	
R26	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T54	
T62	Observation 405 419	alto riesgo de
#51	AnnotatorNotes T62	C0332167; High risk of; Finding
R27	Before Arg1:T62 Arg2:T15	
R28	Experiences Arg1:T49 Arg2:T62	
R29	Speculation Arg1:T51 Arg2:T15	
R31	Experiences Arg1:T52 Arg2:T16	
R32	Experiences Arg1:T52 Arg2:T17	
R33	Experiences Arg1:T52 Arg2:T18	
R34	Experiences Arg1:T52 Arg2:T19	
R35	Experiences Arg1:T52 Arg2:T20	
R36	Location_of Arg1:T21 Arg2:T20	
R37	Experiences Arg1:T52 Arg2:T39	
R40	Location_of Arg1:T24 Arg2:T23	
R41	Location_of Arg1:T27 Arg2:T26	
R42	Location_of Arg1:T40 Arg2:T28	
R43	Location_of Arg1:T29 Arg2:T28	
R44	Location_of Arg1:T41 Arg2:T30	
R45	Negation Arg1:T58 Arg2:T59	
R46	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T59	
R47	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T59	
R48	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T59	
T63	Observation 972 983	alto riesgo
#52	AnnotatorNotes T63	C4319571; High risk; Finding
R49	Negation Arg1:T57 Arg2:T31	
T64	Quantifier_or_Qualifier 1177 1185	adecuado
A8	Assertion T64 Negated
#53	AnnotatorNotes T64	C0205411; Adequate; Qualitative Concept
R50	Has_Quantifier_or_Qualifier Arg1:T31 Arg2:T64	
R51	Negation Arg1:T57 Arg2:T64	
R52	Causes Arg1:T43 Arg2:T32	
R53	Causes Arg1:T35 Arg2:T32	
R54	Causes Arg1:T44 Arg2:T32	
R55	Causes Arg1:T36 Arg2:T32	
R56	Used_for Arg1:T43 Arg2:T33	
R57	Used_for Arg1:T43 Arg2:T34	
R58	Used_for Arg1:T35 Arg2:T33	
R59	Used_for Arg1:T35 Arg2:T34	
R60	Used_for Arg1:T44 Arg2:T33	
R61	Used_for Arg1:T44 Arg2:T34	
R62	Experiences Arg1:T49 Arg2:T15	
R1	Experiences Arg1:T46 Arg2:T8	
#54	AnnotatorNotes T4	C0199230; Screening for cancer; Diagnostic Procedure
A9	Experiencer T46 Patient
A10	Experiencer T49 Patient
A11	Experiencer T52 Patient
